R&D JP Morgan 2023 - Stefan Weber and Ravi Anand pharmaphorum sits down with Stefan Weber and Ravi Anand of neurology-focused biotech Newron.
Sales & Marketing Sponsored Investing in healthcare futures: Elia Stupka and Paul Tunnah Angelini Ventures is an new investment fund seeking companies transformational in healthcare.
R&D Optimisation of signal management in pharmacovigilance Signal management is a fundamental aspect of pharmacovigilance, required by regulatory agencies
R&D Sponsored Data security and trust essential for driving data forward i... Pharma brands need to be clear that data initiatives are backed by secure, compliant systems.
R&D JP Morgan 2023 – Claudia Ulbrich Last month, pharmaphorum sat down with Claudia Ulbrich, CEO of Germany-based Cardior.
R&D How connected compliance technology will improve pharmaceuti... Regulatory and compliance issues have weighed down the pharmaceutical environment for decades.
News UK's Mission divests kidney drug to Dimerix for $292m Mission Therapeutics has struck a deal to out-license a drug for acute kidney injury to Australia's Dimerix, sharpening its focus on CNS diseases.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
